Teva’s Acticlate generic launches

NORTH WALES, Pa. — Teva Pharmaceuticals has introduced its generic of Acticlate (doxycycline hyclate) tablets, the company announced Wednesday. The drug is indicated to reduce the development of drug-resistant bacteria.

“Our customers count on Teva for a continuous supply of new generic products,” Teva COO North America generics Maureen Cavanaugh said. “With the launch of doxycycline hyclate tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”

Teva’s generic will be available in 75- and 150-mg dosage strengths.